Mirum Pharmaceuticals, Inc. today announced its participation in the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) annual meeting taking place November ...

Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, received positive feedback ...

StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note released on Thursday morning. The firm issued a sell rating on the specialty ...

The delusions of parasitosis abated and his bipolar disorder was in control. Delusions of parasitosis manifest with a patient's firm belief of infestation with insects and pruritus. Patients often ...

In dermatology, suggestions given during trance may help decrease skin pain and pruritus, intervene in ... and effects on seizure disorders, pain control, and healing in the same individual ...

Psoriasis is an autoimmune disorder that causes pruritus. This condition occurs when your immune system overreacts, causing rapid skin cell turnover which leads to swollen and itchy patches. It's ...

a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme ...

The event will feature a panel of leaders in the field of neuropathic pruritus who will discuss ... in notalgia paresthetica (NP), a neuropathic disorder with significant unmet need ...

You just indulged in a long, relaxing shower, but when it comes time to towel off, you find that your skin didn't enjoy the ...

Nippon Chemiphar Co. Ltd. has disclosed morphinan derivatives acting as κ-opioid receptor agonists reported to be useful for the treatment of cough, pain, pruritus, substance abuse and dependence, and ...

The FDA has approved oxycodone hydrochloride (RoxyBond) for the management of severe pain when other treatments have proved ...

In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused ...